JF
ANIK icon

Jump Financial’s Anika Therapeutics ANIK Stock Holding History

Jump Financial’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,121
Closed -$193K – 1860
2025
Q4 		$193K Buy
+20,121
New +$193K ﹤0.01% 1758
2024
Q2 		– Sell
-15,300
Closed -$389K – 1781
2024
Q1 		$389K Buy
15,300
+4,100
+37% +$99.2K 0.01% 1313
2023
Q4 		$254K Sell
11,200
-23,789
-68% -$492K 0.01% 1427
2023
Q3 		$652K Buy
+34,989
New +$726K 0.02% 876
2023
Q1 		– Sell
-10,978
Closed -$325K – 1556
2022
Q4 		$325K Sell
10,978
-1,722
-14% -$49K 0.02% 985
2022
Q3 		$302K Sell
12,700
-1,100
-8% -$25.3K 0.01% 1146
2022
Q2 		$308K Buy
+13,800
New +$308K 0.01% 1051
2021
Q4 		– Sell
-11,200
Closed -$477K – 1356
2021
Q3 		$477K Buy
+11,200
New +$461K 0.03% 490

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jump Financial's ANIK Position: Q1 2026 in Review

Jump Financial sold out of Anika Therapeutics (ANIK) in Q1 2026, closing a stake of 20,121 shares — an estimated $193K sold.

Jump Financial first reported a position in ANIK in Q3 2021 and held it in 8 quarters. The position peaked at $652K in Q3 2023. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Jump Financial reported no remaining Anika Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 20,121 Anika Therapeutics shares in Q1 2026, an estimated $193K.
  • Jump Financial first reported a position in Anika Therapeutics in Q3 2021 and held it in 8 quarters.
  • Jump Financial's Anika Therapeutics position peaked at $652K in Q3 2023.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.